Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis

Pediatric Infectious Disease Journal

Volumn 25, Issue 3, 2006, Pages 270-272

  McLeod, Rima ^a   Khan, Asif Rashid ^b   Noble, Gwendolyn A ^a   Latkany, Paul ^a   Jalbrzikowski, Jessica ^a   Boyer, Kenneth ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b MICHAEL REESE HOSPITAL   (United States)

^c RUSH UNIVERSITY   (United States)

Author keywords

Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome; Hypersensitivity syndrome; Sulfadiazine; Toxoplasma gondii

Indexed keywords

AMINOTRANSFERASE; CORTICOSTEROID; COTRIMOXAZOLE; DAPSONE; FOLINIC ACID; PREDNISONE; PYRIMETHAMINE; SULFADIAZINE; SULFONAMIDE;

ABDOMINAL PAIN; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; CHORIORETINITIS; CONGENITAL TOXOPLASMOSIS; DISEASE SEVERITY; DRUG CHOICE; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS SYNDROME; EOSINOPHILIA; FEMALE; FEVER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; SKIN MANIFESTATION; SWELLING; TOXOPLASMA GONDII;

ANIMALS; ANTIPROTOZOAL AGENTS; CHILD; CHORIORETINITIS; DRUG HYPERSENSITIVITY; DRUG THERAPY, COMBINATION; EOSINOPHILIA; FEMALE; HUMANS; PYRIMETHAMINE; RECURRENCE; SEVERITY OF ILLNESS INDEX; SULFADIAZINE; TOXOPLASMA; TOXOPLASMOSIS, OCULAR;

EID: 33644892247     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000202070.59190.9a     Document Type: Article

References (12)

1. Bachot N, Roujeau JC. Differential diagnosis of severe cutaneous drug eruptions: review. Am J Clin Dermatol. 2003;4:561-572.
2. Tas S, Simonart T. Drug rash with eosinophilia and systemic symptoms (DRESS syndrome): review. Acta Clin Belg. 1999;54:197-200.
3. Bosdure E, Cano A, Roquelaure B, et al. Oxcarbazepine and DRESS syndrome: a paediatric cause of acute liver failure. Arch Pediatr. 2004;11:1073-1077.
4. Passeron T, Ndir MC, Aubron C, Hovete P. Drug rash with eosinophilia and systemic symptoms (DRESS) due to streptomycin. Acta Dermatol Venereol. 2004;84:92-93.
5. Ghislain PD, Bodarwe AD, Vanderdonckt O, Tennstedt D, Marot L, Lachapelle JM. Drug-induced eosinophilia and multisystemic failure with positive patch-test reaction to spironolactone: DRESS syndrome. Acta Dermatol Venereol. 2004;84:65-68.
6. Marrakchi C, Kanoun F, Kilani B, et al. Allopurinol induced DRESS syndrome. Rev Med Intern. 2004;25:252-254.
7. Itha S, Kumar A, Dhingra S, Choudhuri G. Dapsone induced cholangitis as a part of dapsone syndrome: a case report. BMC Gastroenterol. 2003;3:21.
8. Lanzafame M, Rovere P, De Checchi G, Trevenzoli M, Turazzini M, Parrinello A. Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy. Scand J Infect Dis. 2001;33:475-476.
9. Lachgar T, Touil Y. The drug hypersensitivity syndrome or DRESS syndrome to phenobarbital. Allerg Immunol (Paris). 2001;33:173-175.
10. Queyrel V, Catteau B, Michon-Pasturel U, et al. DRESS (drug rash with eosinophilia and systemic symptoms) syndrome after sulfasalazine and carbamazepine: report of two cases. Rev Med Intern. 2001;22:582-586.
11. Ichiche M, Kiesch N, De Bels D. DRESS syndrome associated with HHV-6 reactivation. Eur J Intern Med. 2003;14:498-500.
12. Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update: review. Dermatology. 2003;206:353-356.